COMPARISON OF EFFICACY OF FIXED-DOSE ROSUVASTATIN PLUS EZETIMIBE COMBINATION THERAPY VERSUS ROSUVASTATIN MONOTHERAPY IN CORONARY ARTERY DISEASE PATIENTS. RMSR [Internet]. 2025 Aug. 14 [cited 2025 Aug. 17];3(8):539-45. Available from: https://www.medscireview.net/index.php/Journal/article/view/1865